Cargando…

Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature

BACKGROUND: Chronic tuberculous empyema (CTE) is a rare and unusual, low grade and protracted, infection of the pleural space resulting in marked thickening, even calcification of the visceral and parietal pleura. Historically its management has been extraordinarily challenging. Differential penetra...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Richard, Barrie, James, Peloquin, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542105/
https://www.ncbi.nlm.nih.gov/pubmed/26265445
http://dx.doi.org/10.1186/s12879-015-1093-7
_version_ 1782386486553870336
author Long, Richard
Barrie, James
Peloquin, Charles A.
author_facet Long, Richard
Barrie, James
Peloquin, Charles A.
author_sort Long, Richard
collection PubMed
description BACKGROUND: Chronic tuberculous empyema (CTE) is a rare and unusual, low grade and protracted, infection of the pleural space resulting in marked thickening, even calcification of the visceral and parietal pleura. Historically its management has been extraordinarily challenging. Differential penetration of anti-TB drugs into the pleural space has resulted in acquired drug resistance and surgery to remove the empyema or close a complicating bronchopleural fistula (BPF) has been technically difficult or unacceptably hazardous. On the basis of limited experience, the combination of tube thoracostomy or catheter drainage and high-end dosing of anti-TB drugs has been recommended as an initial approach to these lesions. Herein we report the first well documented case of closure of a BPF and cure of a CTE using this approach. The chances of a favorable outcome are improved, we suggest, by using therapeutic drug monitoring (TDM) to guide high-end drug dosing. CASE PRESENTATION: An 84 year old male immigrant to Canada from Croatia was diagnosed with a CTE after he developed a BPF. The diagnosis was made 62 years after what was, in retrospect, an episode of tuberculous pleurisy. He was treated with computed tomography-guided catheter drainage and TDM-guided high-end dosed anti-TB drugs (serum and pleural fluid drug concentrations) over a 10 month period. Sustained closure of the BPF and mycobacteriologic cure of the CTE was achieved. Drug concentrations in the present case and all other reported cases are summarized and interpreted. CONCLUSION: When serum concentrations of the anti-TB drugs isoniazid, pyrazinamide and ethambutol at the high end of the normal range are achieved, pleural fluid concentrations at the low end of the normal range may be anticipated in CTE. Though highly protein bound drugs such as rifampin and moxifloxacin appear to penetrate CTEs less well, their free concentrations in the pleural space may be proportionately higher on account of lower protein concentrations. Interventional radiology and TDM increase the chances that conservative management of CTE will be successful.
format Online
Article
Text
id pubmed-4542105
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45421052015-08-21 Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature Long, Richard Barrie, James Peloquin, Charles A. BMC Infect Dis Case Report BACKGROUND: Chronic tuberculous empyema (CTE) is a rare and unusual, low grade and protracted, infection of the pleural space resulting in marked thickening, even calcification of the visceral and parietal pleura. Historically its management has been extraordinarily challenging. Differential penetration of anti-TB drugs into the pleural space has resulted in acquired drug resistance and surgery to remove the empyema or close a complicating bronchopleural fistula (BPF) has been technically difficult or unacceptably hazardous. On the basis of limited experience, the combination of tube thoracostomy or catheter drainage and high-end dosing of anti-TB drugs has been recommended as an initial approach to these lesions. Herein we report the first well documented case of closure of a BPF and cure of a CTE using this approach. The chances of a favorable outcome are improved, we suggest, by using therapeutic drug monitoring (TDM) to guide high-end drug dosing. CASE PRESENTATION: An 84 year old male immigrant to Canada from Croatia was diagnosed with a CTE after he developed a BPF. The diagnosis was made 62 years after what was, in retrospect, an episode of tuberculous pleurisy. He was treated with computed tomography-guided catheter drainage and TDM-guided high-end dosed anti-TB drugs (serum and pleural fluid drug concentrations) over a 10 month period. Sustained closure of the BPF and mycobacteriologic cure of the CTE was achieved. Drug concentrations in the present case and all other reported cases are summarized and interpreted. CONCLUSION: When serum concentrations of the anti-TB drugs isoniazid, pyrazinamide and ethambutol at the high end of the normal range are achieved, pleural fluid concentrations at the low end of the normal range may be anticipated in CTE. Though highly protein bound drugs such as rifampin and moxifloxacin appear to penetrate CTEs less well, their free concentrations in the pleural space may be proportionately higher on account of lower protein concentrations. Interventional radiology and TDM increase the chances that conservative management of CTE will be successful. BioMed Central 2015-08-12 /pmc/articles/PMC4542105/ /pubmed/26265445 http://dx.doi.org/10.1186/s12879-015-1093-7 Text en © Long et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (http://creativecommons.org/licenses/by/4.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Long, Richard
Barrie, James
Peloquin, Charles A.
Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title_full Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title_fullStr Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title_full_unstemmed Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title_short Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
title_sort therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542105/
https://www.ncbi.nlm.nih.gov/pubmed/26265445
http://dx.doi.org/10.1186/s12879-015-1093-7
work_keys_str_mv AT longrichard therapeuticdrugmonitoringandtheconservativemanagementofchronictuberculousempyemacasereportandreviewoftheliterature
AT barriejames therapeuticdrugmonitoringandtheconservativemanagementofchronictuberculousempyemacasereportandreviewoftheliterature
AT peloquincharlesa therapeuticdrugmonitoringandtheconservativemanagementofchronictuberculousempyemacasereportandreviewoftheliterature